Burning Rock Biotech Limi...

6.01
-0.30 (-4.75%)
At close: Mar 03, 2025, 3:45 PM
6.01
0.00%
After-hours: Mar 03, 2025, 03:46 PM EST

Burning Rock Biotech Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -653.69M -971.23M -796.7M -407.24M -169.16M -177.5M -131.28M
Depreciation & Amortization 133.4M 124.1M 47.77M 33.31M 31.36M 24.68M 21.31M
Stock-Based Compensation 260.72M 326.78M 282.43M 173.22M 22.79M 5.09M 4.05M
Other Working Capital -65.92M -6.33M 28.64M 108.74M -53.08M 19.73M -12.71M
Other Non-Cash Items 55.94M 57.22M 35.61M 15.07M 1.81M 3.74M 5.84M
Deferred Income Tax n/a n/a 15.39M n/a 15.62M 1.37M 1.16M
Change in Working Capital -52.16M 6.33M -62.4M 112.1M -130.46M -6.16M -34.79M
Operating Cash Flow -255.78M -456.81M -477.89M -73.54M -228.04M -148.78M -133.7M
Capital Expenditures -9.38M -62.03M -213.45M -79.54M -45.73M -24.71M -23.01M
Acquisitions n/a n/a 2.53M 3.97M 401K n/a -2.37M
Purchase of Investments n/a n/a -63.92M -348.42M -408.63M n/a -165.71M
Sales Maturities Of Investments n/a 65.6M 358.5M 318M 107.6M 130.68M 574K
Other Investing Acitivies -1.2M -11.03M -1.96M -3.32M -303K 122K -557K
Investing Cash Flow -9.3M -7.46M 81.7M -109.31M -346.66M 106.09M -191.08M
Debt Repayment n/a -2.37M -44.81M -20.59M -81.6M 82.89M 11.45M
Common Stock Repurchased -6.98M -71.83M -4.27M n/a -3.64M -1.5M -9.06M
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -41.85M -12.04M -3.82M 334.43M 656.97M 500K 351.78M
Financial Cash Flow -48.83M -86.24M -52.9M 2.17B 571.74M 83.39M 354.17M
Net Cash Flow -310.05M -513.84M -486.09M 1.83B 2.91M 40.55M 17.98M
Free Cash Flow -265.17M -518.84M -691.33M -153.08M -273.77M -173.5M -156.72M